Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators

被引:8
|
作者
Salum, L. B. [1 ]
Polikarpov, I. [1 ]
Andricopulo, A. D. [1 ]
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecn Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
estrogen receptor; hormone replacement therapy; ER beta binding affinity; HQSAR;
D O I
10.1080/10629360701698811
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The estrogen receptor-beta subtype (ERP) is an attractive drug target for the development of novel therapeutic agents for hormone replacement therapy. Hologram quantitative structure-activity relationships (HQSAR) were conducted on a series of 6-phenylnaphthalene and 2-phenylquinoline derivatives, employing values of ER binding affinity. A training set of 65 compounds served to derive the models. The best statistical HQSAR model (q(2) =0.73 and r(2) = 0.9 1) was generated using atoms, bonds, connections and donor and acceptor as fragment distinction parameters, and fragment size default (4-7) with hologram length of 199. The model was used to predict the binding affinity of an external test set of 16 compounds, and the predicted values were in good agreement with the experimental results. The Final HQSAR model and the information obtained from 2D contribution maps should be useful for the design of novel ERP modulators having improved affinity.
引用
收藏
页码:711 / 727
页数:17
相关论文
共 50 条
  • [31] STRUCTURE-ACTIVITY RELATIONSHIPS IN CYPROHEPTADINE SERIES
    ENGELHARDT, EL
    ZELL, HC
    SAARI, WS
    CHRISTY, ME
    COLTON, CD
    JOURNAL OF MEDICINAL CHEMISTRY, 1965, 8 (06) : 829 - +
  • [32] Comparative pharmacology of a series of selective estrogen receptor modulators.
    Adrian, MD
    Cole, HW
    Shetler, PK
    Rowley, ER
    Magee, DE
    Pell, T
    Zeng, G
    Sato, M
    Byrant, HU
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T590 - T590
  • [33] Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists
    Tarzia, G
    Duranti, A
    Tontini, A
    Spadoni, G
    Mor, M
    Rivara, S
    Plazzi, PV
    Kathuria, S
    Piomelli, D
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (18) : 3965 - 3973
  • [34] Structure-based quantitative structure-activity relationship modeling of estrogen receptor β-ligands
    Dong, Xialan
    Hilliard, Solomon G.
    Zheng, Weifan
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (08) : 933 - 945
  • [35] Nociceptin /Orphanin FQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity Relationships
    Mustazza, Carlo
    Pieretti, Stefano
    Marzoli, Francesca
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (20) : 2353 - 2384
  • [36] Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands
    Gao, H
    Williams, C
    Labute, P
    Bajorath, J
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1999, 39 (01): : 164 - 168
  • [37] Selective Estrogen Receptor Modulators
    Petersen, Nicole M.
    Briggs, Amber L.
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2005, 3 (01): : 19 - 30
  • [38] Selective Estrogen Receptor Modulators
    An, Ki-Chan
    ASIAN SPINE JOURNAL, 2016, 10 (04) : 787 - 791
  • [39] Selective estrogen receptor modulators
    Haskell, SG
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (05) : 469 - 476
  • [40] Selective estrogen receptor modulators
    Bryant H.U.
    Reviews in Endocrine and Metabolic Disorders, 2002, 3 (3) : 231 - 241